Becker Capital Management Inc Johnson & Johnson Transaction History

Becker Capital Management Inc

$3.04 Billion
Q3 2024

A detailed history of Becker Capital Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Becker Capital Management Inc holds 256,308 shares of JNJ stock, worth $37.3 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares

256,308

Previous 255,277 0.4%

Holding current value

$37.3 Million

Previous $37.3 Million 11.33%

% of portfolio

1.37%

Previous 1.28%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$145.48 - $167.38 $149,989 - $172,568	1,031 Added 0.4%	256,308 $41.5 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $655,052 - $715,847	-4,537 Reduced 1.75%	255,277 $37.3 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $1.22 Million - $1.28 Million	7,850 Added 3.12%	259,814 $41.1 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $173,555 - $189,384	-1,192 Reduced 0.47%	251,964 $39.5 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $452,921 - $507,387	-2,908 Reduced 1.14%	253,156 $39.4 Million
Q2 2023 Aug 11, 2023	BUY	$154.35 - $166.11 $661,544 - $711,947	4,286 Added 1.7%	256,064 $42.4 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $602,991 - $719,597	-3,992 Reduced 1.56%	251,778 $39 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $98,202 - $110,211	613 Added 0.24%	255,770 $45.2 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $508,996 - $566,385	-3,155 Reduced 1.22%	255,157 $41.7 Million
Q2 2022 Aug 04, 2022	BUY	$168.19 - $186.01 $465,381 - $514,689	2,767 Added 1.08%	258,312 $45.9 Million
Q1 2022 May 12, 2022	BUY	$158.14 - $179.59 $233,414 - $265,074	1,476 Added 0.58%	255,545 $45.3 Million
Q4 2021 Feb 08, 2022	SELL	$155.93 - $173.01 $7,952 - $8,823	-51 Reduced 0.02%	254,069 $43.5 Million
Q3 2021 Oct 14, 2021	BUY	$161.5 - $179.47 $1 Million - $1.11 Million	6,196 Added 2.5%	254,120 $41 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $74,317 - $79,718	-466 Reduced 0.19%	247,924 $40.8 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $315,324 - $351,188	-2,060 Reduced 0.82%	248,390 $40.8 Million
Q4 2020 Feb 10, 2021	SELL	$137.11 - $157.38 $858,034 - $984,884	-6,258 Reduced 2.44%	250,450 $39.4 Million
Q3 2020 Nov 09, 2020	SELL	$140.38 - $153.83 $265,458 - $290,892	-1,891 Reduced 0.73%	256,708 $38.2 Million
Q2 2020 Aug 11, 2020	SELL	$128.81 - $155.51 $3.86 Million - $4.66 Million	-29,940 Reduced 10.38%	258,599 $36.4 Million
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $5.47 Million - $7.57 Million	-49,173 Reduced 14.56%	288,539 $37.8 Million
Q4 2019 Feb 11, 2020	BUY	$127.5 - $146.44 $290,317 - $333,443	2,277 Added 0.68%	337,712 $49.3 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $2.59 Million - $2.9 Million	20,424 Added 6.48%	335,435 $43.4 Million
Q2 2019 Aug 08, 2019	BUY	$131.15 - $144.24 $304,005 - $334,348	2,318 Added 0.74%	315,011 $43.9 Million
Q1 2019 May 08, 2019	SELL	$125.72 - $139.79 $12.1 Million - $13.5 Million	-96,617 Reduced 23.6%	312,693 $43.7 Million
Q4 2018 Feb 04, 2019	SELL	$122.84 - $147.84 $4.65 Million - $5.6 Million	-37,892 Reduced 8.47%	409,310 $52.8 Million
Q3 2018 Nov 05, 2018	SELL	$121.58 - $142.88 $246,077 - $289,189	-2,024 Reduced 0.45%	447,202 $61.8 Million
Q2 2018 Aug 03, 2018	BUY	$119.4 - $131.76 $1.13 Million - $1.25 Million	9,478 Added 2.16%	449,226 $54.5 Million
Q1 2018 May 07, 2018	BUY	$125.1 - $148.14 $1.82 Million - $2.16 Million	14,549 Added 3.42%	439,748 $56.4 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $1.06 Million - $1.17 Million	-8,116 Reduced 1.87%	425,199 $59.4 Million
Q3 2017 Nov 02, 2017	BUY	$129.47 - $135.38 $492,115 - $514,579	3,801 Added 0.88%	433,315 $56.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	429,514	429,514 $56.8 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.

Account

Becker Capital Management Inc Johnson & Johnson Transaction History